So far, direct evidence for CAFs inducing T cell suppression via arginase has not been provided, although clinical data clearly show that ARG2 overexpression by CAFs predisposes to poor overall survival in pancreatic cancer [24] and ARG2 production by CAF has been observed in unrelated solid tumors, too [49]. The gene discussed is ARG2; the disease is pancreatic neoplasm.